Screener
Bioventus BVS D&A
D&A at other companies
Other financials
Where this comes from
Reported directly by Bioventus in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
FAQ
- What is Bioventus's D&A?
- Bioventus (BVS) reported D&A of $10.95M in Q2 2026.
- How has Bioventus's D&A changed year-over-year?
- Bioventus's D&A decreased by 9.2% year-over-year, from $12.05M to $10.95M.
- What is the long-term trend for Bioventus's D&A?
- Over 4 years (2021 to 2025), Bioventus's D&A has grown at a 7.8% compound annual growth rate (CAGR), from $34.88M to $47.01M.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Bioventus's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude